Generics: Pay-For-Delay, Patent Settlements, Reverse Payment, Price-Fixing & Market Allocation

Virtual
24 June 2021
Hosted By: Concurrences

How has “pay-for-delay” and reverse payment in pharmaceutical patent settlements been impacted since FTC v. Actavis?

Director Dr. David Blackburn will speak during a session called “Generics: Pay-For-Delay, Patent Settlements, Reverse Payment, Price-Fixing & Market Allocation” at Concurrences’ 2nd Annual Antitrust in Life Sciences Conference. Dr. Blackburn and other panelists from White & Case, Novartis, and the United States FTC will provide an analysis of the current legal and economic landscape of generics in the pharmaceutical industry.

NERA Economic Consulting is proud to sponsor this conference bringing together life sciences leaders in antitrust.

For more information on the conference and to register, please visit the Concurrences website

To contact us about this event, please click here.